Koers Signal Genetics Inc Nasdaq
Aandelen
US8266401046
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
16/05 | Transcript : Viridian Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 04:35 PM | |
09/05 | VIRIDIAN THERAPEUTICS, INC. : Oppenheimer herhaalt koopadvies | ZM |
Omzet 2024 * | 370K 342K | Omzet 2025 * | 330K 304K | Marktkapitalisatie | 773 mln. 713 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -230 mln. -212 mln. | Nettowinst (verlies) 2025 * | -266 mln. -245 mln. | EV/omzet 2024 * | 838 x |
Nettoliquiditeiten 2024 * | 462 mln. 426 mln. | Nettoliquiditeiten 2025 * | 625 mln. 576 mln. | EV/omzet 2025 * | 448 x |
K/w-verhouding 2024 * |
-3,27
x | K/w-verhouding 2025 * |
-3,09
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,26% |
Recentste transcriptie over Signal Genetics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 01-05-23 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 03-01-18 |
Tomas Kiselak
CHM | Chairman | 38 | 28-10-20 |
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+67,53% | 63,85 mld. | |
-0,77% | 41,83 mld. | |
+45,66% | 40,65 mld. | |
-10,72% | 27,12 mld. | |
+13,30% | 26,52 mld. | |
-22,79% | 18,69 mld. | |
+4,70% | 12,73 mld. | |
+24,10% | 12,11 mld. | |
+27,41% | 12,07 mld. |
- Beurs
- Aandelen
- Koers VRDN
- Koers